Chapter 317: GeneCorp Filing
Chapter 317: Chapter 317: GeneCorp Filing
Chapter 317: GeneCorp Filing
The filing ran to twenty-four pages.
Cole had written longer documents. This one was not long because it needed to be. It was long because the Assessors’ Board required specific evidence categories for a resource classification petition, and GeneCorp’s legal division had been very clear about what would and would not hold at preliminary review.
He sat at his Kael’s Seat office on the fourteenth morning back from the eastern zones and read the draft from the beginning.
The argument was sound. The Gene Distribution Network predated the Guild’s eastern division by ten thousand years. It was not built by the Guild. It was not built by the carrier. It was built by a civilization that was no longer present to claim it. Under continental resource law, structures predating current institutional authority — especially those with documented commercial output at the surface — fell under public resource classification, with extraction rights subject to licensing.
The output data was there: Zone 20’s measured Gene Energy Output increase, documented by the Guild’s own eastern division instruments. Public record. GeneCorp’s western analysts had confirmed matching readings from their own Zone 20 surface monitors.
He moved through sections four, five, and six without pausing.
Section nine was where he slowed down.
Current extraction without the integration process produces biological rejection at Elite grade and above, he had written. GeneCorp acknowledges this. GeneCorp does not argue that current extraction methods are sufficient for high-grade material. GeneCorp argues that the integration process — currently the exclusive capability of one carrier — constitutes a technical requirement that can be developed independently, and that this petition seeks extraction rights contingent on that development.
He read this paragraph again.
It was accurate. It was also incomplete.
The incomplete part was specific. He had spent two weeks after returning from Zone Two reviewing the field data from the extractor event. A zone energy spike lasting thirty seconds. Ten of twelve anchor connections severed. An 18-month delay in the developing entity’s formation timeline — which was not a number, not an instrument reading, but a consequence for something that had been building for over four years.
The entity withdrew. Not broken. It withdrew, the way something pulls back when it has been touched the wrong way.
He had written this in his own notebook, at the Zone Two boundary, the afternoon he had seen the damage. He had not written it into section nine. Section nine said "biological rejection." Biological rejection was accurate. It described the outcome for the person extracting without the process. It did not describe what happened on the other side of that extraction.
He read the paragraph a fourth time. Then he moved to the next page.
Section twelve was the jurisdictional argument. The Guild’s authority over zones was established by treaty and mandate. Mandate applied to active zone management, not to the underlying network infrastructure. The network infrastructure was a different legal category — older than mandate, older than Guild eastern division authority, older than current institutional frameworks entirely.
GeneCorp’s legal division had worked on this argument for six months. Cole had reviewed three drafts and approved the final structure. At the time, he had not known about the Gene Archive. He had not known about the integration process’s three conditions. He had not known that entities could feel what was done to their territory and respond to it.
He had filed the argument that would work before he had all the facts. He was finishing it now because the institutional record needed to be established. Neral’s heritage assessment filing — three documents, all submitted simultaneously, Cole had received the public notice four days ago — would close within the week. Once the Gene Archive was classified as a Guild protected asset, the window for this argument narrowed significantly.
This was standard institutional practice. Be first on the record. Establish standing. Let the Board review the merits.
He did not find this comforting in the way he usually found standard practice comforting.
He read the remainder of the document — sections thirteen through nineteen, the evidentiary package, the legal precedents from western resource disputes, the GeneCorp development capacity statement.
He found what he was looking for in section seventeen: the provisional injunction request.
The injunction asked the Board to suspend any Guild classification proceedings on the Gene Distribution Network and the Gene Archive until the petition was reviewed on its merits. Without it, Neral’s heritage filing would complete its review cycle before the Board reached Cole’s petition. The Gene Archive would be classified first. The petition would then have to argue against an existing classification, which was a different and harder argument.
With the injunction, the status quo held while the Board reviewed both filings simultaneously.
Cole had not wanted to include the injunction. He had told GeneCorp’s Board director this four days ago, directly. The director had been patient and clear: without the injunction, the Guild’s classification would effectively close the question before it opened. The injunction preserved the Board’s ability to review the matter properly. It was the correct legal instrument.
Cole had agreed. The director was right about the process.
He had still not wanted to include it.
The petition made a claim that had merit. The injunction would make the claim by blocking something else first. These were not the same thing, and the difference was not a legal distinction. It was the kind of distinction that showed up in how things felt when you were writing them. Fourteen days removed from a conversation where the carrier had explained three conditions completely, and asked nothing in return.
He turned to the final page.
The certification block. His name required.
He read the petition summary one more time. Four requests: public resource classification of the Gene Distribution Network; extraction rights through licensed commercial processes; development authority for carrier-equivalent extraction technology; regulatory standing in all future governance proceedings on gene zones and the Gene Archive.
The fourth point was his. He had added it after the director’s final review. The director had not asked for it, had not objected to it. Cole had included it because he believed it was the most important of the four.
Ungoverned gene evolution was not a theoretical risk. The zone event at Zone Two had been produced by a fragment extractor, which was the mildest of GeneCorp’s extraction instruments. The higher-grade tools would produce proportionally larger disruptions. If those tools ever reached the Gene Archive — if any party, commercial or institutional or otherwise, reached the Gene Archive without proper governance in place — the consequences would be far larger than an 18-month delay in a developing entity’s formation timeline.
The Guild could not manage this alone. They did not have the resources, the commercial capacity, or the regulatory reach. The Board could mandate governance frameworks but lacked the instruments to enforce them across the eastern territory. Commercial participation was the only structure that had ever produced sustained, funded, accountable governance of resource zones in the history of the continental authority.
He believed this. He had believed it for fifteen years, across three resource disputes, two of which had resolved because commercial governance had been structured early enough to matter.
He signed.
The relay transmitted at the fourteenth hour.
The filing was received by the Guild eastern division and the Assessors’ Board at the seventeenth hour.
Cole walked to the window. Kael’s Seat below him was moving through its evening change — the research district clearing out, the town district filling up, the lamps coming on in sequence from the Guild Hall outward.
He thought about the carrier somewhere in the eastern territory, surveying the next set of zones. Probably already past Zone Four. Probably working through terrain that no institutional framework had ever touched.
He pulled out his own notebook — not the GeneCorp relay forms, but the one he had carried since his first eastern field assignment. He opened it to the page from five weeks ago. Zone Two’s boundary, afternoon light, after the entity withdrew.
The entity withdrew. Not damaged — withdrew. It knew something had been done to it.
He looked at this for a moment.
Then he turned to the next blank page.
He began writing the carrier-equivalent technology development framework — his own draft, not GeneCorp’s. The argument that the petition had committed to, without yet building. If the Board granted the petition, GeneCorp would need to show it could actually develop what it had claimed. If the Board denied it, the framework would still be necessary — because whatever governance structure emerged would need to answer the question of what happened when the carrier was not available and a gene event occurred.
The argument that got him here was not good enough for what came next. He had known this when he signed.
The work was to make it better.
He wrote until the lamp ran low. He refilled it without stopping.